School of Medicine, Creighton University, Omaha, NE, USA.
Am J Hosp Palliat Care. 2023 Aug;40(8):926-935. doi: 10.1177/10499091221123274. Epub 2022 Sep 6.
Osteosarcoma is the most common form of bone cancer, but the utilization of palliative care (PC) in patients with this cancer has not previously been investigated in the National Cancer Database (NCDB). Patients diagnosed with osteosarcoma (2004-2017) were identified within the NCDB. Cross tabulations with Chi-square analysis were performed to evaluate frequencies of palliative care use by patient, facility, and tumor characteristics. Multivariate logistic binary regression was performed to evaluate relationships between patient, treatment facility, and tumor characteristics and the use of palliative care. A total of 7498 patients were analyzed with 2.8% of patients diagnosed having any form of palliative care utilization. Of this group, 53.37% received PC within the first 12 months after diagnosis. Of the 2.8% of patients receiving PC the most common forms of PC utilized were non-curative symptom-directed surgery, radiation, or chemotherapy, or a combination of these modalities (56.7%). Palliative care usage was increased in patients with greater tumor diameter, tumors in the bones of the midline, or stage IV tumors. Palliative care usage was decreased in patients living within 25-49 miles of their treatment facility, those living in pacific states, those with chondroblastic osteosarcoma, or those with private insurance. Palliative care use in patients with osteosarcoma increases with tumor stage, tumor size, or more proximal tumors, but overall utilization remains markedly low. Future studies should further define these patterns of care and help expand the utilization of PC.
骨肉瘤是最常见的骨癌形式,但以前在国家癌症数据库(NCDB)中没有调查过这种癌症患者使用姑息治疗(PC)的情况。在 NCDB 中确定了诊断为骨肉瘤(2004-2017 年)的患者。通过卡方分析进行交叉表分析,以评估患者、医疗机构和肿瘤特征对姑息治疗使用的频率。采用多元逻辑二项式回归分析评估患者、治疗机构和肿瘤特征与姑息治疗使用之间的关系。共分析了 7498 例患者,其中 2.8%的患者被诊断为使用姑息治疗。在这一组中,53.37%的患者在诊断后 12 个月内接受了 PC。在接受 PC 的 2.8%的患者中,最常见的 PC 形式是非治愈性症状导向手术、放疗或化疗,或这些方式的组合(56.7%)。肿瘤直径较大、中线骨骼中的肿瘤或 IV 期肿瘤的患者中,姑息治疗的使用增加。居住在治疗机构 25-49 英里范围内、居住在太平洋各州、患有软骨母细胞瘤或拥有私人保险的患者,姑息治疗的使用减少。骨肉瘤患者的姑息治疗使用率随着肿瘤分期、肿瘤大小或更靠近近端的肿瘤而增加,但总体利用率仍然明显较低。未来的研究应进一步确定这些护理模式,并帮助扩大姑息治疗的使用。